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In vitro protein expression is an important method of obtaining large amounts of viral proteins to 
investigate their biological properties. The S1 glycoprotein of infectious bronchitis virus, due to its 
effective immune-dominant role is an appropriate candidate for production of recombinant vaccine 
against infectious bronchitis disease. In this study, the S1 gene fragment of infectious bronchitis virus 
strain793/B was amplified using reverse transcriptase-polymerase chain reaction (RT-PCR) and purified. It 
was then cloned into pPICZαA a secretory expression vector of Pichia pastoris. The insertion was proved by 
PCR analysis and isolation of gene from construct by restriction enzymes and finally, it was sequenced. 
After the expression of S1 gene in P. pastoris expression system, it was found that it could be used in the 
production of recombinant vaccines against infectious bronchitis disease. 
 





Infectious bronchitis virus (IBV), one of the prototype of 
the family, Coronaviridae, is the causative agent of an 
acute, highly contagious respiratory, renal and urogenital 
disease characterized by high mortality rates in affected 
flocks and affecting both production and egg quality. 
The IBV genome encodes three major structural proteins; 
the nucleo - capsid, membrane and spikes(S) proteins. 
The S protein is cleaved to the N-terminal S1 and C-
terminal S2 glyco-proteins during post-translational process. 
The S1 glycoprotein is responsible for attachment to the 
host cellular membrane and induces virus-neutralizing 
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Abbreviations: IBV, Infectious bronchitis virus; IB, infectious 
bronchitis; RT-PCR, transcriptase-polymerase chain reaction; 
ELISA, enzyme-linked immunosorbent assay. 
al., 1986; Moore et al., 1997; King and Cavanagh, 1991). 
Although the S1 subunit is highly variable (Cavanagh et 
al., 1988, 1992), previous studies demonstrated that it is 
an excellent candidate for developing subunit vaccines 
against infectious bronchitis (IB). The corresponding 
monoclonal antibodies (m Abs) were main tools for identi-
fying functional epitopes and for developing the 
diagnostic reagents (Wang et al., 2002; Johnson et al., 
2003; Kapczynski et al., 2003; Zhou et al., 2003). 
The commercial live and inactivated vaccines that have 
been used to control IBV-associated disease in chickens 
(Cavanagh et al., 1997) have some disadvantages. 
Inactivated vaccines are safe but are costly and less 
effective than live attenuated vaccines, while attenuated 
vaccines maybe associated with the emergence of 
variant strains of the virus (Wang et al., 1993; Moore et 
al., 1997; Zhou et al., 2002). The live vaccine strains are 
also spreading in the field (Meulemans et al., 2001). So we 
need vaccines with higher efficacy and fewer side effects. 




Table 1. List of PCR primers. 
 
S/N Primer Sequence(5' to 3') 
1 For-S1 GCCGGAATTCATGTTGGGCAAACCGCT 




In previous studies, some expression systems, such as 
insect cells, Pichia pastoris and potato were used to 
express S1 (Dai et al., 2003; Huang et al., 2003; Zhou et 
al., 2003, 2004). In this study, we cloned the S1 
glycoprotein gene of infectious bronchitis virus serotype 
793/B in pPICZαA a secretory expression vector of P. 




MATERIALS AND METHODS  
 
Virus and viral RNA purification 
 
The IBV was inoculated in 11 days-old specific-pathogen-free chicken 
embryonated eggs at 37°C for 48 h. Then the allantoic fluid was 
harvested from eggs and clarified by low-speed centrifugation. 
Viral RNA was extracted from EM-confirmed virus- positive 
allantoic fluid samples, using high pure viral nucleic acid purification 
kit (Roche), according to the manufacture instruction and the RNA 




Reverse transcriptase-polymerase chain reaction (RT- PCR) 
amplification of S1 gene  
 
The oligonucleotides primers were used in RT-PCR designed 
according to the S1 sequence available in the gene bank database 
(Accession number: AF093793). Also multiple cloning site of 
pPlCZαA a secretory plasmid of P. pastoris expression system 
(Invitrogen) was applied. The sequence of RT- PCR primers is 
shown in Table 1. RT- PCR was performed by using one step RT- 
PCR kit (one step- titan kit, Roche) with a thermal cycling program 
of 45°C for 45 min, to prepare the cDNA and followed by 94°C for 3 
min, 35 amplification cycle of 94°C for 1 min, 59°C for 2 min and 
68°C for 2 min. The final elongation step was 10 min at 68°C. 
 
 
Cloning of S1 gene into pPICZα A  
 
The PCR- product of S1 gene was first cloned in pTZ57R vector of 
T/A cloning system based on the manufacture protocol of the kit 
(Ins T/A clone TM PCR product cloning kit , fermentas) then white 
bacterial colonies were selected and plasmids were extracted using 
high pure plasmid isolation kit (QIA Gene) according to the 
manufacturer and digested with NOT I (MBI fermentas) and ECOR I 
(MBI fermentas). These were confirmed with PCR using forward 
and reverse primers of S1 gene to test the existence and appro-
ximate size of the insert (S1 gene), and it was sent to MWG, 
Germany for DNA sequencing using universal M13 forward and 
reverse primers. The construct, pTZ57R- S1, was then digested by 
Not I and ECOR I restriction enzymes and DNA fragments were 
separated on 1% agarose gel. The DNA band with an approximate 
size was excised from the gel and purified by using high pure PCR 
product purification kit (Roche) according to the manufacture 
protocol. Subsequently, the secretory expression vector pPICZαA 
was digested with the same two restriction enzymes and purified as 
described above. The concentrations of purified product were 
measured by Ependorf nanodrop. After mixing in a 3:1 molecular 
ratio, the purified products were ligated by T4 DNA ligase at 16°C 
overnight and then transformed into Escherichia coli Top10F 
competent cells. Transformants selected on low-salt Luria-Bertani 
(LB) plates containing 25 µg/ml zeocin by digestion of purified 
plasmids and direct colony PCR. 
In order to confirm the integrity of the insert (S1 gene ) and that 
no errors have taken place at the ligation sites, the construct 
pPICZαA-S1 extracted from bacterial colonies, was sent to MWG, 
Germany for DNA sequencing by vector specific primers (AOX 1 
forward and reverse primers) and the sequence of inserts were 
verified. The sequence data obtained were compared with sequence 





The S1 gene of infectious bronchitis virus strain 793/B 
was successfully amplified in RT- PCR with designed 
primers. Analysis of PCR product on agarose gel 
revealed a sharp band with an approximate size of 1.7 kb 
(Figure 1). Purified PCR product was then ligated into T/A 
cloning vector pTZ57R/T and the recombinant plasmids 
were amplified in competent E. coli strain Top 10F. The 
sequences of inserts were verified by sequencing. Then 
purified recombinant plasmids were digested with 
restriction enzymes EcoRІ and NotI. As demonstrated in 
the Figure 2, digestion produced two DNA fragments of 
about 3000 and 1700 bp corresponding to linearized 
vector and insert. 
The insert purified from agarose gel was subsequently 
cloned into the pPICZαA expression vector of P. pastoris 
(Figure 3). PCR amplification of recombinant pPICZαA 
with S1 primers and its digestion with EcoRІ and NotІ 
confirmed the correct size of the insert (Figure 4). To 
confirm the identity of the insert, sequence of S1 gene 
inserted in pPICZαA was determined by sequencing 
using vector specific primers and when compared with 
the original sequence of S1 gene of IBV strain 793/B, did 





In this study, we amplified and cloned the S1 glycoprotein 
gene of the strain 793/B of IBV, in order to express S1 
glycoprotein as a candidate of subunit vaccine in P. 
pastoris expression system. This is the first report of 
cloning of the S1 glycoprotein gene of this IBV strain that 
is regularly used in vaccines in Iran. However, vaccination 
with live attenuated and inactivated IBV is performed in Iran  






Figure 1. PCR product of amplified S1 gene. Lane 1: 
Ladder (100 bp); lane 2: negative control; lane 3: amplified 






Figure 2. Agarose gel electrophoresis of construct (S1-
pTZ57R) digested by EcoRІ and NotІ. Lane1: Ladder (100 







Figure 3. Construct (S1-pPICZαA) agarose gel 







Figure 4. Agarose gel electrophoresis of construct S1-pPICZαA 
digested by EcoRІ and NotІ. Lane 1: ladder (100 bp); lane 2: 





to protect broiler chicken flocks against infectious 
bronchitis; the disease has remained as a serious problem 
and causes significant financial losses. In fact, in all over 
the world, chicken infectious bronchitis has a significant 
economic impact in poultry industry.  
Although other virus polypeptides play a role in protection 
and recovery from infection in the chicken, the S1 glyco-
protein is an excellent candidate for the development of 
the novel IBV vaccines. The S1 protein is a structural 
glycoprotein and the glycosylation modification is impor-
tant for its activity. P. pastoris is a eukaryotic expression 
system with high efficiency and proteins expressed in this 
system can get appropriate post–translational modifications, 
including glycolsylation. Therefore, the P. pastoris system 
is more suitable for the expression of the S1 protein in 
vitro than E. coli (Grinner and Tschopp, 1989; Kukuru 
Zinska et al., 1987; Romanos et al., 1992). In a previous 
report, mice which were vaccinated with the S1 glyco-
protein of IBV, expressed in recombinant vaccinia virus, 
produced antibodies that recognized the S antigen in an 
enzyme-linked immunosorbent assay (ELISA) and 
neutralized IBV infectivity (Tomley et al., 1987). 
Song et al. (1998) have shown that recombinant S1 
glycoprotein expressed in baculovirus induced protective 
immunity against a challenge with virulent IBV in chickens. 
Additionally, Johnson et al. (2003) reported that the S1 
protein of IBV expressed with fowl adenovirus was able 
to induced protective immunity against virulent challenge 
in chickens. In this study, we amplified S1 glycoprotein 
gene coding region of IBV strain 793/B genome and 
cloned it in pPICZαA vector of P. pastoris and sequenced 
after cloning. The result indicates the accuracy of joining 
site and we expect the construct pPICZαA-S1 to be used 
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